Abstract

Summary

This review examines how circadian rhythm disruption, mediated in part by impaired ipRGC-to-SCN photic signaling, contributes to sleep disturbances in Parkinson's disease and its preclinical models. Understanding these mechanisms has practical implications for designing targeted light therapy interventions to improve sleep quality and circadian alignment in Parkinson's patients.
Abstract

Key Findings

  • Melanopsin-expressing ipRGCs relay photic information to the SCN via a monosynaptic pathway, and disruption of this pathway is implicated in circadian and sleep abnormalities in Parkinson's disease.
  • Sleep disturbances are among the most prevalent non-motor symptoms in Parkinson's disease, often preceding motor symptom onset, suggesting circadian disruption may be an early biomarker.
  • Preclinical models of Parkinson's disease recapitulate circadian rhythm disruptions, supporting the use of light-based interventions as a therapeutic target.
Categories

Categories

Sleep & Circadian Health: Reviews circadian rhythm disruption mechanisms in Parkinson's disease, including ipRGC and SCN pathway involvement.
Dementia & Elder Care: Addresses sleep and circadian disturbances specific to Parkinson's disease, a major neurodegenerative condition in aging populations.
The Science of Light: Discusses melanopsin-expressing ipRGCs and their role in relaying photic information to the SCN as relevant to PD pathology.
Authors

Author(s)

J Hunt, EJ Coulson, R Rajnarayanan, H Oster
Publication Date

Publication Year

2022
Citations

Number of Citations

37
View more publications